TCF7L2 rs290487: Dietary Interaction and Glucose Metabolism
The rs290487 polymorphism is an intronic single nucleotide variant within the transcription factor 7-like 2 (TCF7L2) gene, an essential component of the Wnt signaling cascade involved in glucose metabolism. Research indicates that this variant plays a role in nutrigenomics, modulating postprandial glucose and glycemic responses to dietary carbohydrate and dietary fiber intake. Evidence for rs290487 remains limited and population-specific, primarily showing associations with glycemic control and diabetes susceptibility across East Asian and other non-European cohorts.
What each genotype means
Typical glycemic response profile
This genotype is often considered the baseline or reference state in many studies regarding this variant. Research suggests that individuals with this genotype may have a different glycemic response to dietary carbohydrates and fiber compared to those carrying the T allele. Because the evidence linking this specific variant to dietary outcomes is limited and sometimes conflicting, you should focus on overall healthy dietary patterns rather than specific adjustments based on this result.
The C allele is common, with frequencies ranging from approximately 25% to 40% in European and West Asian populations, making the CC genotype relatively frequent in these groups.
Varied glycemic response profile
Carrying one copy of the T allele may influence how your body processes dietary carbohydrates and fiber in relation to postprandial glucose regulation. Some studies suggest that TCF7L2 variants can modulate metabolic markers, though the clinical significance of this specific variant remains a subject of ongoing research. You should discuss your overall metabolic health and dietary goals with a healthcare provider or registered dietitian rather than making significant changes based on this genotype alone.
This heterozygous genotype is frequently observed in populations where both C and T alleles are common, occurring in a significant portion of the population.
Potential altered glycemic sensitivity
Research has associated the TT genotype with potential differences in fasting blood glucose and glycated hemoglobin levels in some studies. This variant is thought to play a role in insulin secretion and glucose metabolism, though the strength of this association can vary significantly between different populations. Because the evidence is limited and complex, this result should not be used to diagnose or manage health conditions; please consult with your clinician regarding your metabolic health.
The TT genotype is less common than the CC or CT genotypes in many European and West Asian populations, reflecting the lower frequency of the T allele in those groups.
Understanding the rs290487 Variant and Genomic Location
The single nucleotide polymorphism rs290487 is situated within an intronic region near the 3-prime end of the TCF7L2 gene on chromosome 10. Rather than changing the amino acid sequence of a protein directly, non-coding intronic variants like rs290487 commonly act by modifying transcriptional efficiency, alternative splicing patterns, or the binding of regulatory transcription factors. Although rs7903146 is considered the primary benchmark variant for TCF7L2 in individuals of European ancestry, genetic architecture varies significantly worldwide. In populations where the European index variants have low frequencies, distinct linkage disequilibrium blocks tag independent functional variation. The rs290487 locus resides in one of these independent linkage disequilibrium blocks, serving as a regional marker for metabolic differences that affect how insulin pathways operate.
Biological Role of the TCF7L2 Gene
TCF7L2 encodes a high mobility group box transcription factor that acts as a central downstream effector in the canonical Wnt/beta-catenin signaling pathway. This pathway plays a crucial physiological role in orchestrating cell growth, survival, and differentiation across several tissues, most notably within pancreatic beta cells and the intestinal epithelium. Within the pancreas, TCF7L2 helps regulate the expression of key genes required for glucose-stimulated insulin secretion, insulin processing, and beta-cell maintenance. Furthermore, the factor is involved in the incretin system, regulating the synthesis and release of glucagon-like peptide-1 (GLP-1) in neuroendocrine L-cells of the gut. Consequently, variation in TCF7L2 can impair insulin production, diminish incretin-stimulated insulin release, and contribute to systemic insulin resistance.
Nutrigenomic Interactions and Glycemic Evidence
In the field of nutrigenomics, rs290487 has garnered interest for how it modifies individual responses to dietary components, especially carbohydrates and dietary fiber. Research suggests that the glycemic impact of meals—including postprandial blood glucose spikes—varies according to rs290487 genotype when interacting with dietary carbohydrate load and fiber quantity. In East Asian populations, such as Han Chinese cohorts, the C allele has also been independently linked to type 2 diabetes risk and gestational diabetes mellitus, with physiological investigations identifying increased insulin resistance. Preliminary studies have likewise explored whether this polymorphism alters therapeutic outcomes with secretagogues like repaglinide or incretin mimetics. However, overall evidence for rs290487 remains limited, with conflicting reports across cohorts such as Chinese Hui populations, underscoring that gene-diet interactions at this locus are complex and variable.
Population Frequency and Ancestral Distribution
The frequency of rs290487 alleles displays considerable variation across global ancestral groups. In European and West Asian populations, the minor C allele frequency typically ranges between 25% and 40%, leaving the T allele as the more frequent variant. In contrast, in several East Asian populations, the C allele is common and frequently represents the major allele, with frequencies observed up to and exceeding 40% to 50%. This divergence stands in contrast to classic European-associated TCF7L2 SNPs like rs7903146, which are rare in East Asia. Because different ancestral populations harbor distinct linkage disequilibrium structures across TCF7L2, associations detected with rs290487 in one group cannot be presumed to exert the same physiological influence or effect size in individuals of different backgrounds.
Interpreting Genetic Results in Daily Life
Understanding your rs290487 genotype provides nutritional insight into potential trends in postprandial glucose handling, but it is not a clinical diagnosis. Carrying an associated allele does not mean you have or will develop diabetes, nor does a protective genotype guarantee normal glycemic regulation. Complex metabolic traits are determined by polygenic architecture combined with lifestyle factors, including physical activity, sleep, total caloric balance, and overall dietary quality. Readers should not initiate, discontinue, or alter the dosing of any glucose-lowering medications or follow extreme dietary regimens based solely on consumer genotyping results. Any changes to medical care, diabetes screening, or drug therapy must be discussed directly with a qualified physician, registered dietitian, or clinical pharmacist.
How common is this variant?
The C allele frequency of rs290487 is approximately 25% to 40% across European and West Asian populations, whereas in East Asian populations it is more common and often constitutes the major allele.
Frequently asked questions
Does having the rs290487 risk allele mean I will get diabetes?
No. Single genetic variants like rs290487 contribute only modest statistical shifts in risk rather than causing disease outright. Type 2 diabetes is a multifactorial condition influenced by hundreds of genetic loci alongside environmental factors like diet, physical activity, and body composition.
How does rs290487 influence my response to dietary carbohydrates?
Preliminary nutrigenomics research indicates that the variant may alter how efficiently the body handles post-meal blood sugar levels after eating carbohydrates. Diets rich in dietary fiber and complex, low-glycemic carbohydrates appear to help moderate postprandial glucose responses in carriers of the responsive allele.
Why is rs290487 studied more often in East Asian populations than European populations?
In European populations, other TCF7L2 variants like rs7903146 account for the strongest genetic signals, but those variants are rare in East Asian groups. Researchers evaluate rs290487 because it resides in an independent linkage disequilibrium block that is more common and informative in East Asian cohorts.
Should I adjust my diabetes medications if I know my rs290487 genotype?
No, you should never modify your prescription medications based on personal genetic test results. Although exploratory studies have observed differences in therapeutic responses to certain oral agents, any adjustments to medication selection or dosing must be guided by your physician or clinical pharmacist.
Sources & further reading
Educational information only, last refreshed 9/5/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs290487?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in TCF7L2
This variant in the TCF7L2 gene is one of the strongest genetic risk factors for the development of type 2 diabetes across multiple ethnic groups.
Variant in TCF7L2 consistently associated with altered pancreatic beta-cell function and predisposition to type 2 diabetes.
Resides within the TCF7L2 genomic locus, which is strongly linked to altered glucose regulation and type 2 diabetes susceptibility.
This variant is a well-established marker within the TCF7L2 locus, which is recognized as the most potent genetic risk factor for type 2 diabetes across multiple ethnic groups.
Intronic variant in TCF7L2 strongly associated with increased risk of Type 2 Diabetes through impaired insulin secretion.
This variant is one of the strongest genetic risk factors for Type 2 diabetes, affecting insulin secretion.